Physician Publications
June 3, 2022
KRAS Inhibitor Shrinks Tumors in Over 40% of NSCLC Patients
Read More
June 3, 2022
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation
Read More
June 3, 2022
Adagrasib Induces Promising Efficacy, Deep Responses in KRAS G12C NSCLC
Read More
June 3, 2022
ASCO 2022 | KRYSTAL-1: activity and safety of adagrasib in patients with advanced/metastatic KRASG12Cm NSCLC
Read More
June 3, 2022
Dr. Spira on the Potential Role of Adagrasib in NSCLC
Read More
June 3, 2022
Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting - Alexander I. Spira, MD, PhD, FACP
Read More
96
